<DOC>
	<DOCNO>NCT00986505</DOCNO>
	<brief_summary>The effect intravenous lidocaine infusion manifestation fibromyalgia manifestation record 4 week treatment . Pain intensity rat numerical scale.The combination 240 mg intravenous lidocaine ( week ) 25 mg amitriptyline 4 week modify pain intensity manifestation patient fibromyalgia .</brief_summary>
	<brief_title>Intravenous Lidocaine Fibromyalgia</brief_title>
	<detailed_description>Thirty patient range age 18 60 year , fibromyalgia ( American College Rheumatology criterion : pain four quadrant body least 3 month minimum 11 18 tender point ) study . Other manifestation also record : sleep disorder , fatigue , subjective edema , depression , paresthesia . Criteria exclusion alteration thyroid , rheumatological , renal hepatic function ; trauma ; rheumatic , neuromuscular psychiatric disease ; infectious arthropathy ; pain syndrome ; drug hypersensitivity , pregnancy . All patient receive amitriptyline dose 12.5 mg first week 25 mg subsequent 4 week . Patients group 1 ( n = 15 ) receive 125 mL 0.9 % saline patient group 2 ( n = 15 ) receive 240 mg lidocaine dilute 125 mL 0.9 % saline . The solution infuse period 1 h , week , 4 week ( T1 , T2 , T3 T4 ) .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>18 60 year , fibromyalgia ( American College Rheumatology criterion : pain four quadrant body least 3 month minimum 11 18 tender point Thyroid , rheumatological , renal hepatic function Trauma Rheumatic , neuromuscular psychiatric disease Infectious arthropathy Other pain syndrome Drug hypersensitivity ; AND Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>lidocaine</keyword>
	<keyword>fibromyalgia</keyword>
	<keyword>intravenous lidocaine</keyword>
	<keyword>manifestation</keyword>
</DOC>